Clinical Trial Update: Study of a Tetravalent Dengue Vaccine in Healthy Adult Subjects Aged 18 to 45 Years in India [Phase 2]

View source ↗

Summary

Phase 2 trial update of a tetravalent dengue vaccine in healthy adults in India; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dengue
• Dengue Fever
• Dengue Hemorrhagic Fever

Drugs mentioned

• Tetravalent dengue vaccine

Snippet

Sponsor: Sanofi Pasteur, a Sanofi Company | Conditions: Dengue, Dengue Fever | Phase 2 | Status: COMPLETED | Results posted: 2016-11-03